Home » Topics » BioWorld Science

BioWorld Science
RSS

Eisai describes antitumor sulfonamide

March 15, 1996

OM-174 shows in vivo antitumor activity

March 15, 1996

Glaxo Wellcome reports antitumor drugs

March 15, 1996

Marimastat enters phase II in U.S.

March 15, 1996

IDEC-C2B8 development update

March 15, 1996

Virogenetics cancer vaccine in phase I/II trials

March 15, 1996

Techniclone establishes distribution agreement for Oncolym

March 15, 1996

New antimitotic drugs from Pharmacia & Upjohn

March 15, 1996

More approvals for Taxotere

March 15, 1996

Paclitaxel derivatives from Bristol-Myers Squibb

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.